Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Atherosclerosis ; 201(1): 53-66, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18377911

ABSTRACT

OBJECTIVE: The present study was conducted to characterize the expression of the cysteine protease legumain in murine and human atherosclerotic tissues, and to explore the molecular mechanisms by which legumain may contribute to the pathophysiology of atherosclerosis. METHODS AND RESULTS: Using microarray analysis, legumain mRNA expression was found to increase with development of atherosclerosis in the aorta of aging Apolipoprotein E deficient mice while expression remained at low level and unchanged in arteries of age-matched C57BL/6 control mice. In situ hybridization and immunohistochemical analysis determined that legumain was predominantly expressed by macrophages in the atherosclerotic aorta, in lesions at the aortic sinus and in injured carotid arteries of Apolipoprotein E deficient mice as well as in inflamed areas in advanced human coronary atherosclerotic plaques. In vitro, M-CSF differentiated human primary macrophages were shown to express legumain and the protein could also be detected in the culture media. When tested in migration assays, legumain induced chemotaxis of primary human monocytes and human umbilical vein endothelial cells. CONCLUSIONS: Legumain is expressed in both murine and human atherosclerotic lesions. The macrophage-specific expression of legumain in vivo and ability of legumain to induce chemotaxis of monocytes and endothelial cells in vitro suggest that legumain may play a functional role in atherogenesis.


Subject(s)
Aortic Diseases/enzymology , Aortic Diseases/etiology , Atherosclerosis/enzymology , Atherosclerosis/etiology , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/metabolism , Age Factors , Animals , Aortic Diseases/physiopathology , Apolipoproteins E/physiology , Atherosclerosis/physiopathology , Disease Models, Animal , Endothelial Cells/physiology , Female , Humans , Macrophages/physiology , Male , Mice , Mice, Inbred C57BL , Monocytes/physiology , RNA, Messenger/metabolism
2.
J Proteome Res ; 6(12): 4728-36, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17997517

ABSTRACT

The functional and structural alterations of vascular endothelium contribute to the initiation, progression, and complications of atherosclerotic plaque formation, but limited information is known about the molecular composition and pathways underlying pathological changes during atherosclerosis. We have developed an affinity proteomic strategy for in situ isolation and differential mapping of vascular endothelial proteins in normal and atherosclerotic aorta tissues. The selective labeling was carried out by perfusion of the blood vessels with an active biotin reagent for covalent modification of accessible vascular endothelial proteins. The biotinylated proteins were then enriched by streptavidin affinity chromatography, separated by SDS-PAGE, and subsequently characterized by LC-MS/MS. The described procedure led to the identification of 454 distinct proteins in normal and atherosclerotic aorta tissues. A majority of the proteins are plasma membrane associated and extracellular matrix proteins, and 81 showed altered expressions in atherosclerotic aorta tissue. The differentially expressed proteins are involved in immune and inflammatory responses, cell adhesion, and lipid metabolism. The method provides a new avenue for investigating the endothelial dysfunction and development of atherosclerosis.


Subject(s)
Aorta, Thoracic/chemistry , Atherosclerosis/metabolism , Endothelium, Vascular/chemistry , Perfusion , Proteins/analysis , Proteomics , Animals , Aorta, Thoracic/metabolism , Aorta, Thoracic/pathology , Atherosclerosis/pathology , Biotin , Electrophoresis, Polyacrylamide Gel , Endothelium, Vascular/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Proteins/classification , Proteins/metabolism , Staining and Labeling
3.
J Mol Diagn ; 8(1): 51-61, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16436634

ABSTRACT

Ulcerative colitis (UC) and Crohn's disease (CD) are common inflammatory bowel diseases producing intestinal inflammation and tissue damage. Although emerging evidence suggests these diseases are distinct, approximately 10% of patients remain classified as indeterminate inflammatory bowel disease even after invasive colonoscopy intended for diagnosis. A molecular diagnostic assay using a clinically accessible tissue would greatly assist in the classification of these diseases. In the present study we assessed transcriptional profiles in peripheral blood mononuclear cells from 42 healthy individuals, 59 CD patients, and 26 UC patients by hybridization to microarrays interrogating more than 22,000 sequences. Supervised analysis identified a set of 12 genes that distinguished UC and CD patient samples with high accuracy. The alterations in transcript levels observed by microarray were verified by real-time polymerase chain reaction. The results suggest that a peripheral blood mononuclear cell-based gene expression signature can provide a molecular biomarker that can complement the standard diagnosis of UC and CD.


Subject(s)
Colitis, Ulcerative/diagnosis , Crohn Disease/diagnosis , Gene Expression Profiling , Leukocytes, Mononuclear/chemistry , Molecular Diagnostic Techniques , Adult , Case-Control Studies , Colitis, Ulcerative/blood , Crohn Disease/blood , Humans , Male , Reverse Transcriptase Polymerase Chain Reaction/methods
4.
J Infect Dis ; 187(1): 70-6, 2003 Jan 01.
Article in English | MEDLINE | ID: mdl-12508148

ABSTRACT

Recombinant human interleukin (IL)-11 is a multifunctional cytokine with hematopoietic, immunomodulatory, and epithelial cell protective activities. IL-11alpha receptors are expressed on the luminal surface of intestinal epithelial cells. It was hypothesized that orally administered IL-11 would prevent mucosal damage and protect against microbial invasion in a neutropenic rat model of gram-negative sepsis. IL-11 was administered daily by enteric, coated multiparticle pellets over the course of chemotherapy-induced neutropenia. Compared with the placebo group, IL-11-treated rats retained mucosal mass and had prolonged survival time, reduced pathologic changes, and reduced systemic levels of bacterial endotoxin and concentrations of Pseudomonas aeruginosa in target tissues. Enterocyte messenger RNA levels for tumor necrosis factor-alpha and interferon-gamma revealed that oral IL-11 reduced but did not prevent increased expression of these cytokine genes. These results indicate that orally administered IL-11 may preserve epithelial cell integrity in the presence of cytoreductive chemotherapy. This may represent a new treatment strategy for the prevention of infection in neutropenic hosts.


Subject(s)
Bacteremia/prevention & control , Interleukin-11/administration & dosage , Neutropenia/drug therapy , Administration, Oral , Animals , Female , Interferon-gamma/genetics , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Recombinant Proteins/administration & dosage , Tumor Necrosis Factor-alpha/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...